Market by Product Type, Age Group, Distribution Channel, and Regional Outlook | Forecast 2023-2030
Cough syrup refers to a
medicinal liquid preparation engineered to address coughing and its associated
symptoms. They are carefully formulated with a combination of pharmacologically
active ingredients, such as antitussives, expectorants, antihistamines, and
analgesics, to reduce irritation in the throat and airways, suppress cough
reflexes, encourage mucus clearance, and manage pain. Moreover, they meet
rigorous quality and regulatory requirements, making them a reliable option in
the medical industry for treating respiratory conditions.
According to Triton Market Research’s report, the Global Cough Syrup Market is likely to grow with a CAGR of 3.64% over the forecast period 2023-2030. The market was valued at $5501.63 million in 2022 and is expected to reach a revenue of $7332.12 million by 2030.
Click here to check out our blog on the Global Cough Syrup Market
MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND OPPORTUNITIES
Several
factors, such as the high incidence of respiratory ailments, the vulnerability
of the geriatric population to respiratory diseases, and innovations in cough
syrup formulations, drive the market. The
incidence of respiratory diseases and infections is still a major contributor,
particularly during the flu and cold seasons. An aging population that is more
prone to respiratory illnesses further raises the demand for cough syrups. The
consumer base is also growing because of a variety of formulations like the
creation of sugar-free, herbal syrups and homeopathic and kid-friendly
varieties. Another important factor is the easy availability of
over-the-counter (OTC) medications online and at pharmacies. Additional factors
driving the market include changing lifestyles, higher pollution levels, and
environmental allergens.
The consumption of
cough syrup has been greatly spurred by the rise in respiratory illnesses
around the world. Due to factors including air pollution, smoking, and shifting
weather patterns, illnesses like asthma, chronic obstructive pulmonary disease
(COPD), and respiratory tract infections are becoming more common. According to
the Global Impact of Respiratory Disease Report, COPD affects 200 million
people globally and accounts for 3.2 million deaths annually, ranking it as the
third greatest cause of mortality.
However,
overdosage risks associated with cough syrups, strict regulatory procedures,
and deaths due to the toxicity of ingredients used in cough syrups are all
restraining the cough syrup market. Regulatory agencies
have responded to cough syrup usage and recent reports of deaths linked to
cough syrup overuse, resulting in the implementation of stricter processes
within the market. These procedures are intended to reduce the likelihood of
misuse, safeguard the public’s health, and respond to growing worries about the
improper use of cough syrups comprising potentially dangerous components.
Nevertheless, increasing demand for sugar-free
cough syrups is expected to create lucrative opportunities for the market.
The prevalence of diabetes has been rising more rapidly in low- and
middle-income countries than in high-income countries. People with diabetes are
at increased risk of being infected with the cold or flu virus. In this regard,
keeping blood sugars in control has been a challenge among diabetic patients since
traditional cough syrups include sugar. Hence, artificial sweeteners are being
used in cough syrups, also called sugar substitutes, low-calorie sweeteners, or
nonnutritive sweeteners.
Report scope can be customized per your requirements - Request Free Sample Report
KEY GEOGRAPHIES COVERED:
• North America: United States and Canada
• Europe:
United Kingdom, France, Germany, Spain, Italy, and Rest of Europe
• Asia-Pacific:
China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand,
and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Saudi Arabia, Turkey, South Africa, and Rest of Middle East & Africa
SEGMENTATION ANALYSIS – COUGH SYRUP MARKET:
• Market by Product Type:
o Cough Suppressants
o Combination Medicines
o Expectorants
Combination
medicines are estimated to progress with the highest CAGR during the forecast
period. Combination medicines in cough syrups refer
to formulations that contain a mix of active ingredients targeting different
aspects of respiratory symptoms. These medicines often combine expectorants,
cough suppressants, antihistamines, decongestants, and sometimes even pain
relievers or fever reducers. The demand for combination medicines in the market
is increasing for several reasons, including the desire for convenience and
all-in-one solutions. When individuals experience a combination of symptoms
such as cough, congestion, sore throat, and mild pain, they prefer to address
them simultaneously rather than taking multiple separate medications.
• Market by Age Group:
o Adults
o Adolescents
o Pediatric
• Market by Distribution Channel:
o Retail Pharmacies
o Hospital Pharmacies
o E-Pharmacies
Retail Pharmacies lead the market in terms of revenue. They offer a wide selection of cough syrups, providing consumers with various options to address specific needs. These pharmacies typically stock both prescription and over-the-counter (OTC) cough syrups. Moreover, these establishments are often strategically located in neighborhoods and commercial areas, making them easily accessible to consumers.
COMPETITIVE LANDSCAPE:
The cough syrup market
by company profile helps dive into data about the key players in this industry.
The strategic initiatives for each of the companies considered have been
covered in detail.
Acquisition (April 2021): Pfizer Inc
Pfizer Inc purchased
Amplyx Pharmaceuticals Inc to expand its product line in life-threatening
diseases that affect immune systems.
Divestiture (April 2023): Glenmark Pharma
Glenmark Pharma announced its plan to sell the majority of its 82% ownership in Glenmark Life Sciences in order to lower its debt.
KEY BENEFITS OF THE REPORT:
· Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.
· Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.
· The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.
·
The scope of the market report
comprises the current scenario of the global cough syrup market, along with the
detailed overview of the industry outlook, market dynamics, segmentation
analysis, regional outlook, and competitive landscape for the period 2023-2030.
FAQs:
Q 1) What are the natural or herbal alternatives to
traditional cough syrups?
There are herbal and
natural treatments for mild coughs, including tinctures made from herbs, ginger
tea, and honey-based syrups. These alternatives are becoming more popular as a
result of their alleged safety and lack of negative side effects.
Q 2) What dietary limitations or safety measures should be
observed during cough syrup consumption?
Alcohol should not be
consumed when using cough syrups since it can worsen the sleepiness brought by
certain cough syrups. Additionally, it’s crucial to adhere to the directions on
the product label and get medical advice in case of dietary restrictions
or certain medical conditions.
1. GLOBAL
COUGH SYRUP MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE COUGH SYRUP MARKET
2.1.1. COVID-19
IMPACT
2.1.2. UKRAINE-RUSSIA
WAR IMPACT
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. MARKET
MATURITY ANALYSIS
2.4. INDUSTRY
COMPONENTS
2.4.1. RAW MATERIALS
2.4.2. MANUFACTURERS
2.4.3. DISTRIBUTORS
2.4.4. RETAILERS
2.5. REGULATORY
FRAMEWORK
2.6. KEY
MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT
LAUNCHES
2.6.3. ACQUISITIONS
2.6.4. BUSINESS
DIVESTITURES & EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. HIGH INCIDENCE OF
RESPIRATORY AILMENTS
2.7.2. VULNERABILITY
TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION
2.7.3. INNOVATIONS
IN COUGH SYRUPS
2.8. MARKET
CHALLENGES
2.8.1. OVERDOSE RISKS
ASSOCIATED WITH COUGH SYRUPS
2.8.2. STRICT
REGULATORY REQUIREMENTS
2.8.3. INCREASING
COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS
2.9. MARKET
OPPORTUNITIES
2.9.1. SELF-MEDICATION TRENDS
INCREASE DEMAND FOR OTC DRUGS
2.9.2. HERBAL
COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE
2.9.3. EASE
OF PURCHASE OFFERED BY E-COMMERCE CHANNELS
2.9.4. AVAILABILITY
OF SUGAR-FREE COUGH SYRUPS
2.9.5. GROWING
PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS
2.10. ANALYST
PERSPECTIVE
3. GLOBAL
COUGH SYRUP MARKET – BY PRODUCT TYPE
3.1. COUGH
SUPPRESSANTS
3.2. COMBINATION
MEDICINES
3.3. EXPECTORANTS
4. GLOBAL
COUGH SYRUP MARKET – BY AGE GROUP
4.1. ADULTS
4.2. ADOLESCENTS
4.3. PEDIATRIC
5. GLOBAL
COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL
5.1. RETAIL
PHARMACIES
5.2. HOSPITAL
PHARMACIES
5.3. E-PHARMACIES
6. GLOBAL
COUGH SYRUP MARKET – BY REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY PRODUCT TYPE
6.1.2. MARKET
BY AGE GROUP
6.1.3. MARKET
BY DISTRIBUTION CHANNEL
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.1.1. UNITED
STATES COUGH SYRUP MARKET FORECAST & PROSPECTS
6.1.4.2. CANADA
6.1.4.2.1. CANADA
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2. EUROPE
6.2.1. MARKET
BY PRODUCT TYPE
6.2.2. MARKET
BY AGE GROUP
6.2.3. MARKET
BY DISTRIBUTION CHANNEL
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. UNITED
KINGDOM
6.2.4.1.1. UNITED
KINGDOM COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2.4.2. GERMANY
6.2.4.2.1. GERMANY
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2.4.3. FRANCE
6.2.4.3.1. FRANCE
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2.4.4. ITALY
6.2.4.4.1. ITALY
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2.4.5. SPAIN
6.2.4.5.1. SPAIN
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2.4.6. REST
OF EUROPE
6.2.4.6.1. REST
OF EUROPE COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY PRODUCT TYPE
6.3.2. MARKET
BY AGE GROUP
6.3.3. MARKET
BY DISTRIBUTION CHANNEL
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.1.1. CHINA
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3.4.2. JAPAN
6.3.4.2.1. JAPAN
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3.4.3. INDIA
6.3.4.3.1. INDIA
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3.4.4. SOUTH
KOREA
6.3.4.4.1. SOUTH
KOREA COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3.4.5. ASEAN
COUNTRIES
6.3.4.5.1. ASEAN
COUNTRIES COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3.4.6. AUSTRALIA
& NEW ZEALAND
6.3.4.6.1. AUSTRALIA
& NEW ZEALAND COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3.4.7. REST
OF ASIA-PACIFIC
6.3.4.7.1. REST
OF ASIA-PACIFIC COUGH SYRUP MARKET FORECAST & PROSPECTS
6.4. LATIN
AMERICA
6.4.1. MARKET
BY PRODUCT TYPE
6.4.2. MARKET
BY AGE GROUP
6.4.3. MARKET
BY DISTRIBUTION CHANNEL
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.1.1. BRAZIL
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.4.4.2. MEXICO
6.4.4.2.1. MEXICO
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.4.4.3. REST
OF LATIN AMERICA
6.4.4.3.1. REST
OF LATIN AMERICA COUGH SYRUP MARKET FORECAST & PROSPECTS
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY PRODUCT TYPE
6.5.2. MARKET
BY AGE GROUP
6.5.3. MARKET
BY DISTRIBUTION CHANNEL
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. UNITED
ARAB EMIRATES
6.5.4.1.1. UNITED
ARAB EMIRATES COUGH SYRUP MARKET FORECAST & PROSPECTS
6.5.4.2. TURKEY
6.5.4.2.1. TURKEY
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.5.4.3. SAUDI
ARABIA
6.5.4.3.1. SAUDI
ARABIA COUGH SYRUP MARKET FORECAST & PROSPECTS
6.5.4.4. SOUTH
AFRICA
6.5.4.4.1. SOUTH
AFRICA COUGH SYRUP MARKET FORECAST & PROSPECTS
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
6.5.4.5.1. REST
OF MIDDLE EAST & AFRICA COUGH SYRUP MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1. GSK
PLC
7.1.1. OVERVIEW
7.1.2. PRODUCT
PORTFOLIO
7.1.3. KEY
STRENGTHS
7.1.4. KEY
CHALLENGES
7.2. PFIZER
INC
7.2.1. OVERVIEW
7.2.2. PRODUCT
PORTFOLIO
7.2.3. KEY
STRENGTHS
7.2.4. KEY
CHALLENGES
7.3. NOVARTIS
AG
7.3.1. OVERVIEW
7.3.2. PRODUCT
PORTFOLIO
7.3.3. KEY
STRENGTHS
7.3.4. KEY
CHALLENGES
7.4. RECKITT
BENCKISER GROUP PLC
7.4.1. OVERVIEW
7.4.2. PRODUCT
PORTFOLIO
7.4.3. KEY
STRENGTHS
7.4.4. KEY
CHALLENGES
7.5. THE PROCTER
& GAMBLE COMPANY
7.5.1. OVERVIEW
7.5.2. PRODUCT
PORTFOLIO
7.5.3. KEY
STRENGTHS
7.5.4. KEY
CHALLENGES
7.6. SANOFI
SA
7.6.1. OVERVIEW
7.6.2. PRODUCT
PORTFOLIO
7.6.3. KEY
STRENGTHS
7.6.4. KEY
CHALLENGES
7.7. CIPLA LIMITED
7.7.1. OVERVIEW
7.7.2. PRODUCT
PORTFOLIO
7.7.3. KEY
STRENGTHS
7.7.4. KEY
CHALLENGES
7.8. KENVUE
INC
7.8.1. OVERVIEW
7.8.2. PRODUCT
PORTFOLIO
7.8.3. KEY
STRENGTHS
7.8.4. KEY
CHALLENGES
7.9. ASTRAZENECA
PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT
PORTFOLIO
7.9.3. KEY
STRENGTHS
7.9.4. KEY
CHALLENGES
7.10. ACELLA
PHARMACEUTICALS LLC
7.10.1. OVERVIEW
7.10.2. PRODUCT
PORTFOLIO
7.10.3. KEY STRENGTHS
7.10.4. KEY
CHALLENGES
7.11. THE
HIMALAYA WELLNESS COMPANY
7.11.1. OVERVIEW
7.11.2. PRODUCT
PORTFOLIO
7.11.3. KEY
STRENGTHS
7.11.4. KEY
CHALLENGES
7.12. MERCK
KGAA
7.12.1. OVERVIEW
7.12.2. PRODUCT
PORTFOLIO
7.12.3. KEY
STRENGTHS
7.12.4. KEY
CHALLENGES
7.13. ABBOTT
LABORATORIES
7.13.1. OVERVIEW
7.13.2. PRODUCT
PORTFOLIO
7.13.3. KEY
STRENGTHS
7.13.4. KEY
CHALLENGES
7.14. GLENMARK
PHARMACEUTICALS LIMITED
7.14.1. OVERVIEW
7.14.2. PRODUCT
PORTFOLIO
7.14.3. KEY
STRENGTHS
7.14.4. KEY
CHALLENGES
7.15. DABUR
INDIA LTD
7.15.1. OVERVIEW
7.15.2. PRODUCT
PORTFOLIO
7.15.3. KEY
STRENGTHS
7.15.4. KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL COUGH SYRUP
MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF BUSINESS
DIVESTITURES & EXPANSIONS
TABLE 7: GLOBAL COUGH SYRUP
MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: GLOBAL COUGH SYRUP
MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 9: GLOBAL COUGH SYRUP
MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 10: GLOBAL COUGH SYRUP
MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA COUGH
SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 15: EUROPE COUGH SYRUP
MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 16: EUROPE COUGH SYRUP
MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 17: EUROPE COUGH SYRUP
MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 18: EUROPE COUGH SYRUP
MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC COUGH
SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 23: LATIN AMERICA COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 24: LATIN AMERICA COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 25: LATIN AMERICA COUGH
SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 26: LATIN AMERICA COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 28: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND
AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 30: MIDDLE EAST
AND AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $
MILLION)
FIGURE 1: MARKET MATURITY
ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: GLOBAL COUGH SYRUP
MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE 4: GLOBAL COUGH SYRUP
MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)
FIGURE 5: GLOBAL COUGH SYRUP
MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)
FIGURE 6: GLOBAL COUGH SYRUP
MARKET, BY AGE GROUP, 2022 & 2030 (IN %)
FIGURE 7: GLOBAL COUGH SYRUP
MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)
FIGURE 8: GLOBAL COUGH SYRUP
MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)
FIGURE 9: GLOBAL COUGH SYRUP
MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)
FIGURE 10: GLOBAL COUGH SYRUP
MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)
FIGURE 11: GLOBAL COUGH SYRUP
MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 12: GLOBAL COUGH SYRUP
MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 13: GLOBAL COUGH SYRUP
MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 14: GLOBAL COUGH SYRUP
MARKET, BY REGIONAL OUTLOOK, 2022 & 2030 (IN %)
FIGURE 15: UNITED STATES COUGH
SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 16: CANADA COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: UNITED KINGDOM
COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: GERMANY COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: FRANCE COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: ITALY COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: SPAIN COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: REST OF EUROPE
COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 23: CHINA COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 24: JAPAN COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 25: INDIA COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 26: SOUTH KOREA COUGH
SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 27: ASEAN COUNTRIES
COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 28: AUSTRALIA & NEW
ZEALAND COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 29: REST OF ASIA-PACIFIC
COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 30: BRAZIL COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 31: MEXICO COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 32: REST OF LATIN
AMERICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 33: UNITED ARAB
EMIRATES COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 34: TURKEY COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 35: SAUDI ARABIA COUGH
SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 36: SOUTH AFRICA COUGH
SYRUP MARKET 2023-2030 (IN $ MILLION)
FIGURE 37: REST OF MIDDLE EAST
& AFRICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)